167 related articles for article (PubMed ID: 37581938)
1. SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells.
Chen J; Xu Z; Huang H; Tang Y; Shan H; Xiao F
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37581938
[TBL] [Abstract][Full Text] [Related]
2. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
Wu J; Chai H; Li F; Ren Q; Gu Y
Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
[TBL] [Abstract][Full Text] [Related]
3. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract][Full Text] [Related]
4. The H3K4 methyltransferase SETD1A is required for proliferation of non-small cell lung cancer cells by promoting S-phase progression.
Kang JY; Park JW; Hwang Y; Hahm JY; Park J; Park KS; Seo SB
Biochem Biophys Res Commun; 2021 Jul; 561():120-127. PubMed ID: 34023776
[TBL] [Abstract][Full Text] [Related]
5. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
6. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
7. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
8. SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells.
Liu L; Liu C; Zhang Q; Shen J; Zhang H; Shan J; Duan G; Guo D; Chen X; Cheng J; Xu Y; Yang Z; Yao C; Lai M; Qian C
Hepatology; 2016 Sep; 64(3):814-27. PubMed ID: 27312708
[TBL] [Abstract][Full Text] [Related]
9. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
Fang X; Yan Q; Liu S; Guan XY
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
Shang RZ; Qu SB; Wang DS
World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
[TBL] [Abstract][Full Text] [Related]
12. Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer.
Wu J; Chai H; Shan H; Pan C; Xu X; Dong W; Yu J; Gu Y
Front Cell Dev Biol; 2021; 9():657888. PubMed ID: 34164392
[TBL] [Abstract][Full Text] [Related]
13. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
14. SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells.
Jin ML; Yang L; Jeong KW
Theranostics; 2022; 12(13):5761-5775. PubMed ID: 35966598
[No Abstract] [Full Text] [Related]
15. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH
J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612
[TBL] [Abstract][Full Text] [Related]
16. CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.
Xu M; Fang S; Song J; Chen M; Zhang Q; Weng Q; Fan X; Chen W; Wu X; Wu F; Tu J; Zhao Z; Ji J
Cell Death Dis; 2018 Sep; 9(10):957. PubMed ID: 30237545
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements.
Wu Y; Chen X; Zhao Y; Wang Y; Li Y; Xiang C
Stem Cell Res Ther; 2019 May; 10(1):151. PubMed ID: 31151404
[TBL] [Abstract][Full Text] [Related]
18. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
19. Histone methyltransferase SETD1A participates in lung cancer progression.
Du M; Gong P; Zhang Y; Liu Y; Liu X; Zhang F; Wang X
Thorac Cancer; 2021 Aug; 12(16):2247-2257. PubMed ID: 34219384
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
Kanda M; Sugimoto H; Kodera Y
World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
